General Information:

Id: 2,101 (click here to show other Interactions for entry)
Diseases: Diabetes mellitus, type II - [OMIM]
Insulin resistance
Homo sapiens
article
Reference: Haenni A and Lithell H(1994) Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension Metab. Clin. Exp. 43: 455-461 [PMID: 8159103]

Interaction Information:

Comment Serum cholesterol, total serum and very-low-density lipoprotein (VLDL) triglycerides, and serum urate levels decreased significantly (by 6%, 22%, 29%, and 14%, respectively) during dilevalol treatment, and there was a significant difference between the effects of the two drugs on total, VLDL, and low-density lipoprotein (LDL) triglyceride and serum urate levels.
Formal Description
Interaction-ID: 17236

drug/chemical compound

Dilevalol

decreases_quantity of

drug/chemical compound

Cholesterol

in blood
Drugbank entries Show/Hide entries for